Thierry Diagana - Articles and news items

Novartis

KAE609 shows promise as next generation treatment for malaria

Industry news / 31 July 2014 / Novartis

Novartis published clinical trial results in the New England Journal of Medicine showing that KAE609 (cipargamin), a novel and potent antimalarial drug candidate…

Novartis logo

New malaria target identified with potential to prevent, block, and treat multiple stages of the malaria life cycle

Industry news / 28 November 2013 / Novartis

Novartis scientists have discovered a new drug target for treating malaria…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+